Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

TIMP-3 as a therapeutic target for cancer.

Su CW, Lin CW, Yang WE, Yang SF.

Ther Adv Med Oncol. 2019 Jul 16;11:1758835919864247. doi: 10.1177/1758835919864247. eCollection 2019. Review.

2.

Structural and functional insights into the interaction of sulfated glycosaminoglycans with tissue inhibitor of metalloproteinase-3 - A possible regulatory role on extracellular matrix homeostasis.

Rother S, Samsonov SA, Hofmann T, Blaszkiewicz J, Köhling S, Moeller S, Schnabelrauch M, Rademann J, Kalkhof S, von Bergen M, Pisabarro MT, Scharnweber D, Hintze V.

Acta Biomater. 2016 Nov;45:143-154. doi: 10.1016/j.actbio.2016.08.030. Epub 2016 Aug 18.

PMID:
27545813
3.

Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.

Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP.

Eur J Cell Biol. 1997 Oct;74(2):111-22. Review.

PMID:
9352216
4.

Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.

Lee MH, Rapti M, Knaüper V, Murphy G.

J Biol Chem. 2004 Apr 23;279(17):17562-9. Epub 2004 Jan 20.

5.

Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells.

Deb G, Thakur VS, Limaye AM, Gupta S.

Mol Carcinog. 2015 Jun;54(6):485-99. doi: 10.1002/mc.22121. Epub 2014 Jan 31.

PMID:
24481780
6.

Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice.

Kassiri Z, Oudit GY, Sanchez O, Dawood F, Mohammed FF, Nuttall RK, Edwards DR, Liu PP, Backx PH, Khokha R.

Circ Res. 2005 Aug 19;97(4):380-90. Epub 2005 Jul 21.

PMID:
16037568
7.
8.

Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.

Nakada M, Kita D, Futami K, Yamashita J, Fujimoto N, Sato H, Okada Y.

J Neurosurg. 2001 Mar;94(3):464-73.

PMID:
11235952
9.

Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3.

Zhang L, Zhao L, Zhao D, Lin G, Guo B, Li Y, Liang Z, Zhao XJ, Fang X.

Cancer Gene Ther. 2010 Mar;17(3):171-9. doi: 10.1038/cgt.2009.59. Epub 2009 Oct 2.

PMID:
19798124
10.
11.

Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.

Kubota T, Itagaki M, Hoshino C, Nagata M, Morozumi T, Kobayashi T, Takagi R, Yoshie H.

J Periodontol. 2008 Jan;79(1):166-73. doi: 10.1902/jop.2008.070159 .

PMID:
18166107
12.

Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.

Işlekel H, Oktay G, Terzi C, Canda AE, Füzün M, Küpelioğlu A.

Cell Biochem Funct. 2007 Jul-Aug;25(4):433-41.

PMID:
16615041
13.

Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.

Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang Y, Urbanski SJ.

Am J Pathol. 1998 Dec;153(6):1895-902.

14.

[Key enzymes of degradation and angiogenesis as a factors of tumor progression in squamous cell carcinoma of the cervix].

Solov'eva NI, Timoshenko OS, Kugaevskaia EV, Andreeva IuIu, Zavalishina LE.

Bioorg Khim. 2014 Nov-Dec;40(6):743-51. Russian.

PMID:
25895371
15.

Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.

Batra J, Robinson J, Soares AS, Fields AP, Radisky DC, Radisky ES.

J Biol Chem. 2012 May 4;287(19):15935-46. doi: 10.1074/jbc.M112.341156. Epub 2012 Mar 16.

16.

Gene therapy of melanoma pulmonary metastasis by intramuscular injection of plasmid DNA encoding tissue inhibitor of metalloproteinases-1.

Shi Y, Parhar RS, Zou M, Al-Mohanna FA, Paterson MC.

Cancer Gene Ther. 2002 Feb;9(2):126-32. Erratum in: Cancer Gene Ther 2002 Jul;9(7):631.

17.

Thrombospondin-1 (TSP-1) up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) production in human tumor cells: exploring the functional significance in tumor cell invasion.

John AS, Hu X, Rothman VL, Tuszynski GP.

Exp Mol Pathol. 2009 Dec;87(3):184-8. doi: 10.1016/j.yexmp.2009.09.002. Epub 2009 Sep 9.

18.

Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer.

Hilska M, Roberts PJ, Collan YU, Laine VJ, Kössi J, Hirsimäki P, Rahkonen O, Laato M.

Int J Cancer. 2007 Aug 15;121(4):714-23.

19.

Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation.

Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E, Tartare-Deckert S.

J Biol Chem. 2003 Apr 4;278(14):11888-96. Epub 2003 Jan 15.

20.

Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.

Chaudhary AK, Singh M, Bharti AC, Asotra K, Sundaram S, Mehrotra R.

J Biomed Sci. 2010 Feb 15;17:10. doi: 10.1186/1423-0127-17-10. Review.

Supplemental Content

Support Center